Browsing bySubjectBevacizumab

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 5 of 5

Issue DateTitleAuthor(s)Type
2025Cardioprotective effects of PARP inhibitors for platinum-agent induced cardiotoxicity김명규Article
2024Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines김윤환Article
2019Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041)김윤환Article; Proceedings Paper
2017Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticles이지영Article
2022Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis이정연Review

BROWSE